Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-22-012307

Options or other derivatives

  • Director acquired 8,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Truitt Joseph Director 2022-05-10 Grant or award · Stock Option (Right to Buy) +8,300 8,300 D
Loading xslF345X03/form4.xml…